TipRanks on MSN

Pfizer’s Earnings Shine Amid Analyst Caution

Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer has recently reported solid ...

Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition

Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss ...

2 No-Brainer Dividend Stocks to Buy With $100 in November

While many of the top income stocks on the market are expensive, some can be had for well under $100 per share. Here are two ...

Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal

Pfizer (PFE) wins Metsera (MTSR) buyout after a heated bidding war with Novo Nordisk (NVO), securing a $10B deal for the ...

Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer

Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and ...
The Edge Singapore

Pfizer has sweetened offer for Metsera in bidding war against Novo, Bloomberg reports

The new offer improves upon Pfizer’s earlier proposal for US$86.20 (RM359.97) a share including milestone payments, said the ...

Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports

(Reuters) - Pfizer has submitted a sweetened bid for obesity drug developer Metsera, as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday. The new offer improves upon ...